Coffee With Polio Experts: Dr Ananda Bandyopadhyay

Ananda talks about development of the nOPV2 vaccine its pathway to rollout, and field performance

In this two-part video series, we chat with Dr Ananda Bandyopadhyay, Deputy Director of Polio Technology, Research & Analytics, BMGF, about the new tool in GPEI’s kit to combat cVDPV2: novel oral polio vaccine type 2 (nOPV2).

 


Related News

   28/06/2022
G7 and Commonwealth Heads of Government call for strengthened support to global polio eradication effort
   15/06/2022
Medical doctors and religious teachers play a crucial role in building trust and convincing families to vaccinate their children against polio
   09/06/2022
Sports stars unite for the world’s biggest celebrity football match to raise support toward polio eradication.
   30/05/2022
World Health Assembly challenged to take urgent action before window of opportunity closes to eradicate polio; tackle cVDPVs with same urgency as WPVs
   26/05/2022
Meeting in Berlin focused on supporting vaccine equity and pandemic response in developing countries